| Literature DB >> 16357320 |
Daniela Bischof1, Sherine F Elsawa, George Mantchev, Juhan Yoon, Grace E Michels, Allan Nilson, Shari L Sutor, Jeffrey L Platt, Stephen M Ansell, Gotz von Bulow, Richard J Bram.
Abstract
B-lymphocyte homeostasis and function are regulated by complementary actions of the TNFR family members TACI, BCMA, and BAFF-R, which are expressed by mature B cells. How these receptors are differentially activated is not entirely understood, because the primary ligand BAFF binds to all three. We searched for alternative ligands for TACI using recombinant TACI-Fc fusion protein as a probe and identified syndecan-2 as a new binding partner. TACI binding appears to require heparan sulfate posttranslational modifications of syndecan-2, because free heparin or pretreatment with heparitinase blocked the interaction. Syndecan-2 bound TACI but bound neither BAFF-R nor BCMA. Transfected cells expressing syndecan-2 activated signaling through TACI, as indicated by an NFAT-specific reporter. Syndecan-1 and syndecan-4 were also able to induce TACI signaling in a similar manner. This is the first identification of ligands that selectively activate TACI without simultaneously triggering BCMA or BAFF-R. This finding may help explain the alternative outcomes of signaling from this family of receptors in B cells.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16357320 PMCID: PMC1895754 DOI: 10.1182/blood-2005-01-0256
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113